HISTOGEN
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body. The company’s innovative technology platform utilizes cell-conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address underserved, multi-billion US dollar global markets. It was founded in 2007 by Dr. Gail Naughton and is headquartered in San Diego, California.
HISTOGEN
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
2007-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.histogen.com
Total Employee:
11+
Status:
Active
Contact:
(858) 200-9520
Total Funding:
87.52 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS PHP GoDaddy DNS AWS Global Accelerator
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-05-27 | Conatus Pharmaceuticals | Conatus Pharmaceuticals acquired by Histogen | N/A |
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Histogen
National Science Foundation
National Science Foundation investment in Grant - Histogen
Pineworld Capital
Pineworld Capital investment in Series D - Histogen
Angus Mitchell
Angus Mitchell investment in Series C - Histogen
Lordship Ventures
Lordship Ventures investment in Series C - Histogen
Leonard Lavin
Leonard Lavin investment in Series C - Histogen
National Science Foundation
National Science Foundation investment in Grant - Histogen
Leonard Lavin
Leonard Lavin investment in Series A - Histogen
Angus Mitchell
Angus Mitchell investment in Series A - Histogen
Lordship Ventures
Lordship Ventures investment in Series A - Histogen
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-08 | Histogen Announces CEO Transition |
| 2020-10-19 | Histogen Appoints Moya Daniels as Executive Vice President and Head of Regulatory, Quality and Clinical Operations |
Official Site Inspections
http://www.histogen.com Semrush global rank: 3.78 M Semrush visits lastest month: 3.54 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Histogen"
Histogen - Crunchbase Company Profile & Funding
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body. The company’s innovative …See details»
Histogen Announces Board Approval of Complete Liquidation and …
SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), today announced that its Board of Directors, after extensive consideration of potential strategic …See details»
Histogen Announces Board Approval of Complete Liquidation
Sep 18, 2023 Histogen undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as …See details»
Histogen: Failed biotech offers rare public look inside
Oct 5, 2023 S AN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company ...See details»
Histogen winds down after search for solutions comes up short
Sep 19, 2023 Histogen consigned to history after search for strategic solutions comes up short By James Waldron Sep 19, 2023 8:50am Histogen layoffs Biotech graveyard Biotech closureSee details»
Histogen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Histogen is a company that specializes in regenerative medicine, using a unique biological platform to replace and regenerate damaged tissues within the body. ... The statistics for drugs …See details»
HSTOQ | Histogen Inc. Profile - MarketWatch
3 days ago Histogen, Inc. engages in the development of potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological …See details»
Histogen plans to wind down operations after failing to find a …
Sep 19, 2023 Histogen started out as a private company focused on regenerating tissue in the body. In 2020, its lead drug was meant to be a potential treatment for male pattern baldness. …See details»
Histogen Company Profile 2024: Stock Performance & Earnings
Histogen General Information Description. Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and …See details»
Histogen Company Profile - Office Locations, Competitors ... - Craft
Histogen is a regenerative medicine company. It develops a biological platform that replaces and regenerates tissues in the body. The Histogen technology utilizes human proteins and growth …See details»
Histogen Announces Exclusive Intellectual Property License …
SAN DIEGO, April 03, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class clinical and preclinical …See details»
Histogen Announces Board Approval of Complete Liquidation and ...
Sep 18, 2023 Histogen undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as …See details»
Histogen - LinkedIn
Histogen is a regenerative medicine company developing patented technologies that stimulate the body’s stem cells to regenerate tissues and restore youthful function.See details»
Histogen Announces CEO Transition - GlobeNewswire
Nov 8, 2021 Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications, including joint cartilage regeneration, …See details»
Histogen Announces CEO Transition - Yahoo Finance
SAN DIEGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative …See details»
Histogen Announces Successful Completion of its Merger with
May 27, 2020 For example, we are using forward-looking statements when we discuss Histogen’s future operations and its ability to successfully initiate and complete clinical trials …See details»
Histogen - Company Presentation - YouTube
Oct 22, 2014 Presented by: Gail Naughton, Ph.D., Chairman & CEOHistogen is a regenerative medicine company manufacturing and developing innovative therapies based on the ...See details»
Histogen Announces Closing of $6.5 Million Registered Direct …
SAN DIEGO, June 09, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (Nasdaq: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative …See details»
Histogen Reports Year-End 2022 Results and Provides
Mar 9, 2023 Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class clinical and preclinical small molecule pan-caspase and caspase …See details»
Histogen and Amerimmune Announce Additional Findings from
Aug 16, 2021 Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair …See details»